Viewing Study NCT02073591



Ignite Creation Date: 2024-05-06 @ 2:33 AM
Last Modification Date: 2024-10-26 @ 11:20 AM
Study NCT ID: NCT02073591
Status: COMPLETED
Last Update Posted: 2015-11-05
First Post: 2014-02-19

Brief Title: Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan Regimen
Sponsor: Hyphens Pharma Pte Ltd
Organization: Hyphens Pharma Pte Ltd

Study Overview

Official Title: A Phase IV Open Label Single Arm Multicenter Observational Study to Evaluate the Correlation Between PEST and SCORAD Score in the Management of Atopic Dermatitis With Use of Ceradan Regimen in Children Aged Six Months to Six Years
Status: COMPLETED
Status Verified Date: 2015-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: COPES
Brief Summary: This is a prospective open label single arm and observational and multicenter study to assess the correlation between PEST and SCORAD scores in the management of AD with the Ceradan regimen
Detailed Description: All eligible patients shall apply permitted topical steroids according to standard local practice

For the entire study period patients should apply Ceradan Cream liberally twice daily or more if required and use a non-soap based wash once or twice daily

At the screening visit patients will receive a diary card and will be asked to track their atopic dermatitis symptoms for 12 weeks

Retrospective information on other topical treatments used will be collected at baseline

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None